Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adel Atari

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Nature Structural & Molecular Biology|August 22, 2025
Mechanisms and genomic implications of break-induced replicationAdel Atari, Haoyang Jiang, Roger A Greenberg
Small (Weinheim an Der Bergstrasse, Germany)|August 9, 2023
Reducing Cancer Cell Adhesion using Microtextured SurfacesCaroline McCue, Adel Atari, Sean Parks, et al.
Nature Communications|July 2, 2025
Accelerating cell culture media development using Bayesian optimization-based iterative experimental designHarini Narayanan, Joshua A Hinckley, Rachel Barry, et al.
ACS Nano|October 29, 2025
Alternating Electrochemical Redox-Cycling on Nanocomposite Biointerface for High-Efficiency Enzyme-Free Cell DetachmentCaroline McCue, Wang Hee Lee, Bert Vandereydt, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.
Nature Genetics|September 25, 2023
Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalitiesLiang Chang, Nancy Y Jung, Adel Atari, et al.
Nature Genetics|February 23, 2024
Author Correction: Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalitiesLiang Chang, Nancy Y Jung, Adel Atari, et al.
The Journal of Clinical Investigation|February 27, 2025
Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Nature Structural & Molecular Biology|August 22, 2025
Mechanisms and genomic implications of break-induced replicationAdel Atari, Haoyang Jiang, Roger A Greenberg
Small (Weinheim an Der Bergstrasse, Germany)|August 9, 2023
Reducing Cancer Cell Adhesion using Microtextured SurfacesCaroline McCue, Adel Atari, Sean Parks, et al.
Nature Communications|July 2, 2025
Accelerating cell culture media development using Bayesian optimization-based iterative experimental designHarini Narayanan, Joshua A Hinckley, Rachel Barry, et al.
ACS Nano|October 29, 2025
Alternating Electrochemical Redox-Cycling on Nanocomposite Biointerface for High-Efficiency Enzyme-Free Cell DetachmentCaroline McCue, Wang Hee Lee, Bert Vandereydt, et al.
Biorxiv : the Preprint Server for Biology|September 30, 2024
Identification of potent biparatopic antibodies targeting FGFR2 fusion driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.
Nature Genetics|September 25, 2023
Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalitiesLiang Chang, Nancy Y Jung, Adel Atari, et al.
Nature Genetics|February 23, 2024
Author Correction: Systematic profiling of conditional pathway activation identifies context-dependent synthetic lethalitiesLiang Chang, Nancy Y Jung, Adel Atari, et al.
The Journal of Clinical Investigation|February 27, 2025
Identification of potent biparatopic antibodies targeting FGFR2 fusion-driven cholangiocarcinomaSaireudee Chaturantabut, Sydney Oliver, Dennie T Frederick, et al.
Pageof 1